Estrogen Replacement Therapy in Survivors of Breast Cancer

This publication has 25 references indexed in Scilit:

• Relative risks and benefits of long-term estrogen replacement therapy: a decision analysis.
  1994
• A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription.
  Journal of Clinical Endocrinology & Metabolism, 1993
• Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
  Annals of Internal Medicine, 1992
• Combined oestrogen-progestogen replacement and breast cancer risk
  The Lancet, 1992
• Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes.
  Molecular and Cellular Biology, 1991
• Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee.
  BMJ, 1991
• A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer
  JAMA, 1991
• Long-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women.
  Journal of Clinical Oncology, 1990
• Progestin Regulation of Cellular Proliferation*
  Endocrine Reviews, 1990
• Oestrogen therapy after the menopause — boon or bane?
  The Medical Journal of Australia, 1988